BGC > Buscar Producto > N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide | 956958-53-5
Proveedores de CAS
956958-53-5
|
Identificación | CAS |
956958-53-5 | Formula |
C21H16N6O2S2 |
|
8 Proveedores registrados
Amadis Chemical Company Limited
P.R.China
Más detalles se encuentran aquí
Hangzhou Keying Chem Co., Ltd.
P.R.China
Capot Chemical Co., Ltd.
P.R.China
Más detalles se encuentran aquí
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C21H16N6O2S2 Molecular Weight: 448.52074
Aea.ltd
P.R.China
BOC Sciences
USA
Description: Pilaralisib is a Class 1 phosphatidylinositol 3 kinase (PI3K) family inhibitor. It is an orally bioavailable small molecule, targeting the class I PI3K family of lipid kinases. It is a pyrimidine derivatives compound discovered by Exelixis Inc. It has potential antineoplastic activity. It binds to class 1 PI3Ks in an ATP-competitive manner by inhibiting the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate (PIP3) and inhibiting the activation of the PI3K signaling pathway. - Molecular Weight:448.52
- Boiling Point:638.9±65.0 °C | Condition: Press: 760 Torr
- Purity:>99%
Molecular Formula: C21H16N6O2S2 Canonical SMILES: CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4 InChI: InChI=1S/C21H16N6O2S2/c1-13-6-9-15(10-7-13)31(28,29)27-21-20(23-16-4-2-3-5-17(16)24-21)22-14-8-11-18-19(12-14)26-30-25-18/h2-12H,1H3,(H,22,23)(H,24,27) InChIKey: MQMKRQLTIWPEDM-UHFFFAOYSA-N Solubility: DMSO ≥86mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL Appearance: White to off-white Solid Application: Pilaralisib has potential antineoplastic activity. Storage: -20°C Freezer Synonyms: XL147-II; XL147 II; XL147II; XL147 derivative II; XL147derivativeII; XL147-derivative-II; N-[3-(2,1,3-Benzothiadiazol-5-ylamino)-2-quinoxalinyl]-4-methylbenzenesulfonamide;SAR245408;N-[3-(Benzo[c][1,2,5]thiadiazol-5-ylaMino)quinoxalin-2-yl]-4-MethylbenzenesulfonaMide;PI3K inhibitorX Más detalles se encuentran aquí
Chemlyte Solutions
P.R.China
Más detalles se encuentran aquí
Santa Cruz Biotechnology, Inc.
USA
|